Terazosin dimer impurity (dihydrochloride)

Terazosin dimer impurity dihydrochloride, a dimer of Terazosin, is an impurity of Terazosin. Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist[1].

Product Specifications

CAS Number

[1486464-41-8]

UNSPSC

12352005

Hazard Statement

H315-H319

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/terazosin-dimer-impurity-dihydrochloride.html

Solubility

10 mM in DMSO

Smiles

NC1=C2C=C(OC)C(OC)=CC2=NC(N3CCN(C4=NC(N)=C5C=C(OC)C(OC)=CC5=N4)CC3)=N1.[H]Cl.[H]Cl

Molecular Formula

C24H30Cl2N8O4

Molecular Weight

565.45

Precautions

P264-P280-P302+P352-P362+P364

References & Citations

[1]Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16 (1) :21-8.